X hits on this document

81 views

0 shares

0 downloads

0 comments

4 / 36

CTC NOTICE OF MODIFICATIONS

Grade

Adverse Event Leukocytes (total WBC)

  • 0

    1

2

For BMT studies, if specified in the protocol.

For pediatric BMT studies (using age, race and sex normal values), if specified in the protocol.

Lymphopenia

G2

G3

For pediatric BMT studies (using age, race and sex normal values), if specified in the protocol.

Neutrophils/granulocytes (ANC/AGC)

For BMT studies, if specified in the protocol.

For leukemia studies or bone marrow infiltrative/ myelophthisic process, if specified in the protocol.

G2

The Grade 1 Platelets value was changed to < LLN - 75.0 x 109/L (“<” was deleted).

Platelets

For BMT studies, if specified in the protocol.

For leukemia studies or bone marrow infiltrative/ myelophthisic process, if specified in the protocol.

G2

Transfusion: Platelets

G3

For BMT studies, if specified in the protocol.

Also consider Platelets.

Cancer Therapy Evaluation Program Common Toxicity Criteria, Version 2.0 DCTD, NCI, NIH, DHHS March 1998

3

3

Version 2.0 Publish Date: April 30, 1999

4

G4

G4

Revised March 23, 1998

Document info
Document views81
Page views81
Page last viewedFri Dec 02 18:42:27 UTC 2016
Pages36
Paragraphs1051
Words5565

Comments